Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

Clinical trial NCT05104983 · RECRUITING

Trial details

NCT number: NCT05104983
Sponsor: Darcy Krueger
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberous Sclerosis Complex Epilepsy

Start date: 2021-10-13
Primary completion: 2026-06-30
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.